Contact Us


Your Name (required)

Your Email (required)

Subject

Your Message

government reporting

New Government Compliance Requirements Create Outsourcing Opportunity for Pharmaceutical Manufacturers

DSCSA Deadline and Changing Government Pricing Policies Prompt Partnerships To Increase Efficiency Boca Raton, FL (July 16, 2018) — Conventional pharmaceutical manufacturers are being challenged to increase innovation and reduce costs.  During the past several years, this new financial reality resulted in the development of the virtual manufacturing business model and has increased outsourcing of tasks including government pricing programs traditionally managed internally. A 2016 study1 ...

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.